-
1
-
-
85041509204
-
Extreme dysbiosis of the microbiome in critical illness
-
McDonald, D., Ackermann, G., Khailova, L., Baird, C., Heyland, D., Kozar, R., et al. Extreme dysbiosis of the microbiome in critical illness. mSphere, 1(4), 2016.
-
(2016)
mSphere
, vol.1
, Issue.4
-
-
McDonald, D.1
Ackermann, G.2
Khailova, L.3
Baird, C.4
Heyland, D.5
Kozar, R.6
-
2
-
-
77957367472
-
[Microbiota and enteral nutrition]
-
Schneider, S.M., [Microbiota and enteral nutrition]. Gastroenterol. Clin. Biol. 34:Suppl 1 (2010), S57–S61.
-
(2010)
Gastroenterol. Clin. Biol.
, vol.34
, pp. S57-S61
-
-
Schneider, S.M.1
-
3
-
-
84926346594
-
Probiotics for the prevention of antibiotic-associated diarrhoea in older patients: a systematic review
-
Xie, C., Li, J., Wang, K., Li, Q., Chen, D., Probiotics for the prevention of antibiotic-associated diarrhoea in older patients: a systematic review. Travel Med. Infect. Dis. 13:2 (2015), 128–134.
-
(2015)
Travel Med. Infect. Dis.
, vol.13
, Issue.2
, pp. 128-134
-
-
Xie, C.1
Li, J.2
Wang, K.3
Li, Q.4
Chen, D.5
-
4
-
-
84999116006
-
Reassessing the death risk related to probiotics in critically ill patients
-
Maraolo, A.E., Reassessing the death risk related to probiotics in critically ill patients. Crit. Care, 20(1), 2016, 388.
-
(2016)
Crit. Care
, vol.20
, Issue.1
, pp. 388
-
-
Maraolo, A.E.1
-
5
-
-
84982215474
-
Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis
-
Manzanares, W., Lemieux, M., Langlois, P.L., Wischmeyer, P.E., Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis. Crit. Care, 19, 2016, 262.
-
(2016)
Crit. Care
, vol.19
, pp. 262
-
-
Manzanares, W.1
Lemieux, M.2
Langlois, P.L.3
Wischmeyer, P.E.4
-
6
-
-
85011085705
-
Seven cases of Saccharomyces fungaemia related to use of probiotics
-
Roy, U., Jessani, L.G., Rudramurthy, S.M., Gopalakrishnan, R., Dutta, S., Chakravarty, C., et al. Seven cases of Saccharomyces fungaemia related to use of probiotics. Mycoses, 2017.
-
(2017)
Mycoses
-
-
Roy, U.1
Jessani, L.G.2
Rudramurthy, S.M.3
Gopalakrishnan, R.4
Dutta, S.5
Chakravarty, C.6
-
7
-
-
0345725006
-
The taxonomic position of Saccharomyces boulardii as evaluated by sequence analysis of the D1/D2 domain of 26S rDNA, the ITS1-5.8S rDNA-ITS2 region and the mitochondrial cytochrome-c oxidase II gene
-
van der Aa Kühle, A., Jespersen, L., The taxonomic position of Saccharomyces boulardii as evaluated by sequence analysis of the D1/D2 domain of 26S rDNA, the ITS1-5.8S rDNA-ITS2 region and the mitochondrial cytochrome-c oxidase II gene. Syst. Appl. Microbiol. 26:4 (2003), 564–571.
-
(2003)
Syst. Appl. Microbiol.
, vol.26
, Issue.4
, pp. 564-571
-
-
van der Aa Kühle, A.1
Jespersen, L.2
-
8
-
-
84865240144
-
Adhesion to the yeast cell surface as a mechanism for trapping pathogenic bacteria by Saccharomyces probiotics
-
Tiago, F.C., Martins, F.S., Souza, E.L., Pimenta, P.F., Araujo, H.R., Castro, I.M., et al. Adhesion to the yeast cell surface as a mechanism for trapping pathogenic bacteria by Saccharomyces probiotics. J. Med. Microbiol. 61:Pt 9 (2012), 1194–1207.
-
(2012)
J. Med. Microbiol.
, vol.61
, pp. 1194-1207
-
-
Tiago, F.C.1
Martins, F.S.2
Souza, E.L.3
Pimenta, P.F.4
Araujo, H.R.5
Castro, I.M.6
-
9
-
-
0032919855
-
Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa
-
Castagliuolo, I., Riegler, M.F., Valenick, L., LaMont, J.T., Pothoulakis, C., Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa. Infect. Immun. 67:1 (1999), 302–307.
-
(1999)
Infect. Immun.
, vol.67
, Issue.1
, pp. 302-307
-
-
Castagliuolo, I.1
Riegler, M.F.2
Valenick, L.3
LaMont, J.T.4
Pothoulakis, C.5
-
10
-
-
33645455337
-
Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease
-
McFarland, L.V., Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am. J. Gastroenterol. 101:4 (2006), 812–822.
-
(2006)
Am. J. Gastroenterol.
, vol.101
, Issue.4
, pp. 812-822
-
-
McFarland, L.V.1
-
11
-
-
85000580131
-
Saccharomyces boulardii to prevent antibiotic-associated diarrhea: a randomized, double-masked, placebo-controlled trial
-
(ofw011)
-
Ehrhardt, S., Guo, N., Hinz, R., Schoppen, S., May, J., Reiser, M., et al. Saccharomyces boulardii to prevent antibiotic-associated diarrhea: a randomized, double-masked, placebo-controlled trial. Open Forum Infect. Dis., 3(1), 2016 (ofw011).
-
(2016)
Open Forum Infect. Dis.
, vol.3
, Issue.1
-
-
Ehrhardt, S.1
Guo, N.2
Hinz, R.3
Schoppen, S.4
May, J.5
Reiser, M.6
-
12
-
-
84861908072
-
Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial
-
Pozzoni, P., Riva, A., Bellatorre, A.G., Amigoni, M., Redaelli, E., Ronchetti, A., et al. Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial. Am. J. Gastroenterol. 107:6 (2012), 922–931.
-
(2012)
Am. J. Gastroenterol.
, vol.107
, Issue.6
, pp. 922-931
-
-
Pozzoni, P.1
Riva, A.2
Bellatorre, A.G.3
Amigoni, M.4
Redaelli, E.5
Ronchetti, A.6
-
13
-
-
85018468803
-
Effectiveness of probiotics in reducing the incidence of Clostridium difficile-associated diarrhea in elderly patients: a systematic review
-
Vernaya, M., McAdam, J., Hampton, M.D., Effectiveness of probiotics in reducing the incidence of Clostridium difficile-associated diarrhea in elderly patients: a systematic review. JBI Database Syst. Rev. Implement. Rep. 15:1 (2017), 140–164.
-
(2017)
JBI Database Syst. Rev. Implement. Rep.
, vol.15
, Issue.1
, pp. 140-164
-
-
Vernaya, M.1
McAdam, J.2
Hampton, M.D.3
-
14
-
-
84858637080
-
Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea
-
Dinleyici, E.C., Eren, M., Ozen, M., Yargic, Z.A., Vandenplas, Y., Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea. Expert Opin. Biol. Ther. 12:4 (2012), 395–410.
-
(2012)
Expert Opin. Biol. Ther.
, vol.12
, Issue.4
, pp. 395-410
-
-
Dinleyici, E.C.1
Eren, M.2
Ozen, M.3
Yargic, Z.A.4
Vandenplas, Y.5
-
15
-
-
70350441932
-
Efficacy and safety of Saccharomyces boulardii in amebiasis-associated diarrhea in children
-
Savaş-Erdeve, S., Gökay, S., Dallar, Y., Efficacy and safety of Saccharomyces boulardii in amebiasis-associated diarrhea in children. Turk. J. Pediatr. 51:3 (2009), 220–224.
-
(2009)
Turk. J. Pediatr.
, vol.51
, Issue.3
, pp. 220-224
-
-
Savaş-Erdeve, S.1
Gökay, S.2
Dallar, Y.3
-
16
-
-
54049107346
-
Saccharomyces boulardii fungaemia in an intensive care unit patient treated with caspofungin
-
Lolis, N., Veldekis, D., Moraitou, H., Kanavaki, S., Velegraki, A., Triandafyllidis, C., et al. Saccharomyces boulardii fungaemia in an intensive care unit patient treated with caspofungin. Crit. Care, 12(2), 2008, 414.
-
(2008)
Crit. Care
, vol.12
, Issue.2
, pp. 414
-
-
Lolis, N.1
Veldekis, D.2
Moraitou, H.3
Kanavaki, S.4
Velegraki, A.5
Triandafyllidis, C.6
-
17
-
-
0036278211
-
Seven cases of fungemia with Saccharomyces boulardii in critically ill patients
-
Lherm, T., Monet, C., Nougière, B., Soulier, M., Larbi, D., Le Gall, C., et al. Seven cases of fungemia with Saccharomyces boulardii in critically ill patients. Intensive Care Med. 28:6 (2002), 797–801.
-
(2002)
Intensive Care Med.
, vol.28
, Issue.6
, pp. 797-801
-
-
Lherm, T.1
Monet, C.2
Nougière, B.3
Soulier, M.4
Larbi, D.5
Le Gall, C.6
-
18
-
-
77951026738
-
Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA)
-
Cohen, S.H., Gerding, D.N., Johnson, S., Kelly, C.P., Loo, V.G., McDonald, L.C., et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect. Control Hosp. Epidemiol. 31:5 (2010), 431–455.
-
(2010)
Infect. Control Hosp. Epidemiol.
, vol.31
, Issue.5
, pp. 431-455
-
-
Cohen, S.H.1
Gerding, D.N.2
Johnson, S.3
Kelly, C.P.4
Loo, V.G.5
McDonald, L.C.6
-
19
-
-
84900563292
-
Saccharomyces cerevisiae fungemia, a possible consequence of the treatment of Clostridium difficile colitis with a probioticum
-
Santino, I., Alari, A., Bono, S., Teti, E., Marangi, M., Bernardini, A., et al. Saccharomyces cerevisiae fungemia, a possible consequence of the treatment of Clostridium difficile colitis with a probioticum. Int. J. Immunopathol. Pharmacol. 27:1 (2014), 143–146.
-
(2014)
Int. J. Immunopathol. Pharmacol.
, vol.27
, Issue.1
, pp. 143-146
-
-
Santino, I.1
Alari, A.2
Bono, S.3
Teti, E.4
Marangi, M.5
Bernardini, A.6
|